Disparities in adherence to and persistence with antihypertensive regimens: An exploratory analysis from a community-based provider network

Journal of the American Society of Hypertension

Volumn 6, Issue 3, 2012, Pages 201-209

  Ishisaka, Denis Y ^a   Jukes, Trevor ^a   Romanelli, Robert J ^a   Wong, Ken S ^b   Schiro, Timothy A ^a  

^a SUTTER HEALTH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

health disparities; Hypertension; medication possession ratio; proportion of days covered

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASIAN AMERICAN; CAUCASIAN; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC DIFFERENCE; EXPLORATORY RESEARCH; FEMALE; HEALTH DISPARITY; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; PACIFIC ISLANDER; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; CALIFORNIA; COMMUNITY NETWORKS; DATABASES, FACTUAL; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS DISPARITIES; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84859984500     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2012.02.004     Document Type: Article

References (42)

1. Ebrahim S. Detection, adherence and control of hypertension for the prevention of stroke: a systematic review. Health Technol Assess 1998;2:1-78.
2. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-98. (Pubitemid 24165020)
3. Burke LE, Dunbar-Jacob J. Adherence to medication, diet, and activity recommendations:from assessment to maintenance. J Cardiovasc Nurs 1995;9:62-79.
4. Bosworth HB. Medication adherence. In: Bosworth HB, Weinberger M, editors. Patient treatment adherence: concepts, interventions, and measures. Mahwah, NJ: Lawrence Erlbaum Associates; 2005. P. 147-94.
5. Degli Esposti L, Di Martino M, Saragoni S, Sgreccia A, Capone A, Buda S, et al. Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies. J Clin Hypertens (Greenwich) 2004;6:76-84.
6. Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, Buda S, et al. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 2002;24:1347-57. (Pubitemid 35026158)
7. Juncos LI. Patient compliance and angiotensin converting enzyme inhibitors in hypertension. J Cardiovasc Pharmacol 1990;15:S22-5. (Pubitemid 20115354)
8. Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J 1991;121:664-9.
9. Luscher TF, Vetter W. Adherence to medication. J Hum Hypertens 1990;4:43-6. (Pubitemid 20071260)
10. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 1997;157:1921-9. (Pubitemid 27398356)
11. Joint National Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
12. Kennedy J, Coyne J, Sclar D. Drug affordability and prescription noncompliance in the United States: 1997-2002. Clin Ther 2004;26:607-14. (Pubitemid 38586462)
13. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97. (Pubitemid 41127293)
14. Taylor DW, Sackett DL, Haynes RB, Johnson AL, Gibson ES, Roberts RS. Compliance with antihypertensive drug therapy. Ann N YAcad Sci 1978;304:390-403. (Pubitemid 8336663)
15. Norman SA, Marconi KM, Schezel GW, Schecter CF, Stolley PD. Beliefs, social normative influences, and compliance with antihypertensive medication. Am J Prev Med 1985;1:10-7. (Pubitemid 16091426)
16. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-7. (Pubitemid 351160875)
17. Lloyd-Jones D, Adams RJ, Brown RM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215.
18. Benner JS, Glynn RJ, Mogun H, Neumann RJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61. (Pubitemid 34787476)
19. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10:3-12. (Pubitemid 46161090)
20. LaFleur J, Thompson CJ, Joish VN, Charland SL, Oderda GM, Brixner DI. Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin. Ann Pharmacother 2006;40:1274-9. (Pubitemid 44204956)
21. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197-203.
22. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
23. Psaty BM, Manolio RA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults:the Cardiovascular Health Study. Arch Intern Med 2002;162:2325-32. (Pubitemid 35332515)
24. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345:479-86. (Pubitemid 32758499)
25. Schectman JM, Bovbjerg VE, Voss JD. Predictors of medication-refill adherence in an indigent rural population. Med Care 2002;40:1294-300.
26. Bosworth HB, Dudley T, Olsen MK, Voils CI, Powers B, Goldstein MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med 2006;119:70.e9-15.
27. Krousel-Wood MA, Munter P, Islam T, Morisky DE, Webber LS. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am 2009;93:753-69.
28. Schoenthaler, Chaplin WF, Allegrante JP, Fernandez S, Diaz-Gloster M, Tobin JN, et al. Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns 2009;75:185-91.
29. Krousel-Wood MA, Munter P, Joyce CJ, Islam T, Stanley E, Holt EW, et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence:findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2010;58:54-61.
30. Ogdegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis 2004;14:3-12. (Pubitemid 38262740)
31. Brown CM, Segal R. Ethnic differences in temporal orientation and its implications for hypertension management. J Health Soc Behav 1996;37:350-61. (Pubitemid 126420645)
32. Dunbar-Jacob JM, Burke LE, Mathews JT. Predictors of patient adherence: patient characteristics. In: Schumaker SA, Scrhon EB, Ockene JK, McBee WL, editors. The handbook of health behavior change. 2nd ed. New York: Springer Publishing Company; 1998. P. 491-512.
33. Kressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med 2001;135:352-66. (Pubitemid 32823242)
34. Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978;88:251-8. (Pubitemid 8282164)
35. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health 1992;82:1607-12.
36. Li WW, Stewart AL, Stotts N, Froelicher ES. Cultural factors associated with antihypertensive medication adherence in Chinese immigrants. J Cardiovasc Nurs 2006;21:354-62.
37. Hsu YH, Mao CL, Wey M. Antihypertensive medication adherence among elderly Chinese Americans. J Transcult Nurs 2010;21:297-305.
38. Padilla R, Steiner JF, Havranek EP, Beaty B, Davidson AJ, Bull S. A comparison of different measures of acculturation with cardiovascular risk factors in Latinos with hypertension. J Immigr Minor Health 2011;13:284-92.
39. Sleath B, Rubin RH, Wurst K. The influence of Hispanic ethnicity on patients' expression of complaints about and problems with adherence to antidepressant therapy. Clin Ther 2003;25:1739-49. (Pubitemid 36801945)
40. Houston TK, Allison JJ, Sussman M, Horn W, Holt CL, Trobaugh J, et al. Culturally appropriate storytelling to improve blood pressure:a randomized trial. Ann Intern Med 2011;154:77-84.
41. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007;120:26-32. (Pubitemid 46026987)
42. Zeng F, Patel BV, Andrews L, Frech-Tamas F, Rudolph AE. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens. Curr Med Res Opin 2010;26:2877-87.